The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 1, 2003, Pages 48-52

  Mansour, Ragga T ^a   Aboulghar, Mohammed A ^a,b   Serour, Gamal I ^a   Al Inany, Hesham G ^a,b   Fahmy, Ibrahim ^a,b   Amin, Yehia ^a  

^a EGYPTIAN IVF ET CENTER   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Clomiphene citrate; Cost effectiveness; GnRH antagonist; Human monopausal gonadotrophins; In vitro fertilisation

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG USE; EVALUATION; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; CHORIONIC GONADOTROPIN; CLOMIPHENE; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; MALE; MENOTROPINS; PREGNANCY; PREGNANCY RATE; SPERM INJECTIONS, INTRACYTOPLASMIC; TRIPTORELIN;

EID: 0037280586     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.820108.x     Document Type: Article

References (22)

1. Forsdahl F, Holst N, Hansen LJ, Bertheussen K. Experience with GnRH agonists in an in vitro fertilization (IVF) program. Acta Obstet Gynecol Scand 1991; 70: 339-42.
2. Hugues JN, Cedrin Durnerin I. GnRH analog protocols revisited I - advantages and doubts. Contracept Fertil Sex 1997; 25: 445-56.
3. FIVNAT 1996 Report. French National register on in vitro fertilization. Contracept Fertil Sex 1997; 25: 499-502.
4. Belaisch-Allart J, Bachelot A, de Mouzon J. Ovulation stimulation. Contracept Fertil Sex 1998; 26: 473-5.
5. Goldfarb JM, Austin C, Lisbona H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilization. Obstet Gynecol 1996; 87: 18-21.
6. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Hum Reprod 1999; 14: 2959-62.
7. Mansour RT, Aboulghar MA, Serour GI, Tawab NA, Amin YM, Sattar MA. Successful intracytoplasmic sperm injection without performing cytoplasmic aspiration. Fertil Steril 1996; 66: 256-9.
8. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994; 9: 788-91.
9. Olivennes F, Fanchin R, Bouchard P, de Ziegler D, Taieb J, Selva J et al. The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil Steril 1994; 62: 468-76.
10. Olivennes F, Fanchin R, Bouchard P, Taieb J, Selva J, Frydman R. Scheduled administration of a gonadotrophin-releasing hormone antagonist (Cetrorelix) on day 8 of in-vitro fertilization cycles: a pilot study. Hum Reprod 1995; 10: 1382-6.
11. Olivennes F, Alvarez S, Bouchard P, Fanchin R, Salat-Baroux J, Frydman R. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 1998; 13: 2411-4.
12. Rongières-Bertrand C, Oliveness F, Righini C, Fanchin R, Taieb J, Hamamah S et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum Reprod, 1999; 14: 683-8.
13. Unfer V, Costabile L, Gerli S, Papaleo E, Marelli G, Di Renzo GC. Low dose of ethinyl estradiol can reverse the antiestrogenic effects of clomiphene citrate on endometrium. Gynecol Obstet Invest 2001; 51: 120-3.
14. Out HJ, Coelingh Bennink HJ. Clomiphene citrate or gonadotrophins for induction of ovulation? Hum Reprod 1998; 13: 2358-6.
15. Messinis IE, Melingos SD. Clomiphene in the 21st century. Hum Reprod 1998; 13: 2362-5.
16. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000; 15: 526-31.
17. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 2000; 73: 314-20.
18. The European Orgalutran Study Group. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000; 15: 1490-8.
19. The European Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum. Reprod 2001; 16: 644-51.
20. Ganirelix Dose-Finding Study Group. A double blind, randomized, dose-finding study to assess the efficacy of the Gn RH-antagonist ganirelix (Org. 37462) to prevent premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation with recombinant follicle stimulating hormone. Hum Reprod 1998; 13: 3023-31.
21. Hernandez R. Embryo implantation: the Rubicon for GnRH antagonists. Human Reprod 2000; 15: 1211-6.
22. Mannaerts B, Gordon K. Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor. Hum Reprod 2000; 15: 1882-3.